Traders sold shares of St. Jude Medical Inc. (NYSE:STJ) on strength during trading hours on Monday. $9.97 million flowed into the stock on the tick-up and $26.98 million flowed out of the stock on the tick-down, for a money net flow of $17.01 million out of the stock. Of all companies tracked, St. Jude Medical had the 0th highest net out-flow for the day. St. Jude Medical traded up $0.31 for the day and closed at $82.01

A number of equities research analysts have commented on the company. Zacks Investment Research raised St. Jude Medical from a “hold” rating to a “buy” rating and set a $68.00 price target on the stock in a report on Friday, April 22nd. Piper Jaffray Cos. cut St. Jude Medical from an “overweight” rating to a “neutral” rating in a report on Thursday, April 28th. BMO Capital Markets raised their price target on St. Jude Medical from $66.00 to $73.00 and gave the company an “outperform” rating in a report on Monday, March 28th. BTIG Research cut St. Jude Medical from a “buy” rating to a “neutral” rating in a report on Monday, April 18th. They noted that the move was a valuation call. Finally, Wedbush cut St. Jude Medical from an “outperform” rating to a “neutral” rating and raised their price target for the company from $70.00 to $84.00 in a report on Friday, July 15th. Twenty-two analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $75.93.

The stock has a 50-day moving average price of $78.71 and a 200 day moving average price of $65.21. The firm has a market cap of $23.64 billion and a price-to-earnings ratio of 35.66.

St. Jude Medical (NYSE:STJ) last issued its earnings results on Wednesday, July 20th. The medical technology company reported $1.06 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $1.06. The business had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.55 billion. During the same period last year, the company posted $1.07 earnings per share. The firm’s revenue for the quarter was up 10.8% on a year-over-year basis. On average, analysts anticipate that St. Jude Medical Inc. will post $4.06 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 29th. Shareholders of record on Thursday, June 30th will be issued a dividend of $0.31 per share. The ex-dividend date is Tuesday, June 28th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.51%.

Several hedge funds have modified their holdings of the company. Schroder Investment Management Group boosted its stake in shares of St. Jude Medical by 127.2% in the fourth quarter. Schroder Investment Management Group now owns 3,103,759 shares of the medical technology company’s stock worth $191,720,000 after buying an additional 1,737,451 shares during the period. Cornerstone Capital Management Holdings LLC. boosted its stake in shares of St. Jude Medical by 484.0% in the fourth quarter. Cornerstone Capital Management Holdings LLC. now owns 505,085 shares of the medical technology company’s stock worth $31,198,000 after buying an additional 418,602 shares during the period. Vanguard Group Inc. boosted its stake in shares of St. Jude Medical by 2.6% in the fourth quarter. Vanguard Group Inc. now owns 16,138,642 shares of the medical technology company’s stock worth $996,883,000 after buying an additional 411,462 shares during the period. Marshall Wace LLP boosted its stake in shares of St. Jude Medical by 396.9% in the fourth quarter. Marshall Wace LLP now owns 286,788 shares of the medical technology company’s stock worth $17,715,000 after buying an additional 229,078 shares during the period. Finally, Dimensional Fund Advisors LP boosted its stake in shares of St. Jude Medical by 32.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 823,890 shares of the medical technology company’s stock worth $50,894,000 after buying an additional 199,858 shares during the period.

St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.